|
J Biol Chem, Vol. 274, Issue 45, 31784-31791, November 5, 1999
Purinoceptors Evoke Different Electrophysiological Responses
in Pancreatic Ducts
P2Y INHIBITS K+ CONDUCTANCE, AND P2X STIMULATES
CATION CONDUCTANCE*
Susanne E.
Hede,
Jan
Amstrup,
Bettina C.
Christoffersen, and
Ivana
Novak
From the August Krogh Institute, Copenhagen University,
Universitetsparken 13, DK-2100 Copenhagen Ø, Denmark
 |
ABSTRACT |
In epithelia, extracellular nucleotides are often
associated with regulation of ion transporters, especially
Cl channels. In this study, we investigated which
purinoceptors are present in native pancreatic ducts and how they
regulate ion transport. We applied whole-cell patch-clamp recordings,
intracellular Ca2+ and pH measurements, and reverse
transcription-polymerase chain reaction (RT-PCR) analysis. The data
show two types of purinoceptors and cellular responses. UTP and ATP
produced large Ca2+ transients, a decrease in intracellular
pH, 8-10-mV depolarization of the membrane voltage, and a decrease in
the whole-cell conductance. The membrane effects were due to closure of
K+ channels, as confirmed by dependence on extracellular
K+. UTP/ATP effects could be associated with
P2Y2 purinoceptors, and RT-PCR revealed mRNAs for
P2Y2 and P2Y4 receptors. On the other hand,
2',3'-O-4-benzoylbenzoyl-ATP induced Ca2+
influx and ~20-mV depolarization of the membrane voltage with a
concomitant increase in the whole-cell conductance. These effects were
dependent on extracellular Na+, not Cl ,
indicating opening of cation channels associated with P2X7
purinoceptors. RT-PCR showed mRNAs for P2X7 and
P2X4 receptors. In microperfused ducts, luminal (but not
basolateral) ATP caused large depolarizations of membrane voltages
recorded with microelectrodes, consistent with luminal localization of
P2X7 receptors. Thus, P2Y2 (and possibly P2Y4) purinoceptors inhibit K+ channels and may
not support secretion in native ducts. P2X7 (and possibly
P2X4) receptors are associated with cation channels and may
contribute to regulation of secretion.
 |
INTRODUCTION |
Extracellular nucleotides are regulators of a wide range of
cellular functions in various cells, including regulators of epithelial transport (1). They act through specific P2 receptors, which, according
to their molecular structure and signal transduction, have been divided
into two distinct receptor families: G protein-coupled receptors (P2Y
receptors) and ligand-gated ion channels (P2X receptors) (1). In
epithelia cultured from upper respiratory airways, intestine, and
exocrine glands, including pancreas, UTP and ATP stimulate
Cl transport through P2Y receptors, which were described
pharmacologically as P2U receptors and, in many cases, may correspond
to the cloned P2Y2 receptors (2-11). However, similar
action of pyrimidines on Cl transport could
also be exerted through P2Y4 or P2Y6 (12, 13). Due to their effects on Cl transport, nucleotides were
proposed as therapeutic agents for treatment of cystic fibrosis, as
they could bypass the defective function of the cystic fibrosis
transmembrane regulator Cl conductance and restore
secretion by activation of a Ca2+-dependent
Cl conductance (8). Interestingly, recent studies on
exocrine glands indicate that the P2Y receptors and associated signal
transduction pathways are not static, but dynamic. For example, the
P2Y2 receptor expression increases dramatically in tissue
culture of salivary gland cells (14), and the P2Y1 receptor
activity changes during the gland development (15). Thus, it is
important to consider which P2 receptors are present in freshly
prepared cells from exocrine glands. Although there is evidence for
some P2Y-type receptors (4, 11, 16, 17), more commonly accounted
purinoceptors are those linked directly to cation influx (18-23).
Occupation of these purinoceptors leads to stimulation of
Cl transport, volume changes, and secretion of enzymes
and peptides (19, 21, 24), but in some cases, interference with the
Ca2+ signaling utilized by other receptor pathways has been
reported (25, 26). These receptors have been described
pharmacologically as P2Z receptors, but it is unclear if these
correspond to the pore-forming P2X7 receptors originally
found in immunoreactive cells (1). Interestingly, in situ
hybridization analysis shows P2X4 receptors on salivary
gland acini, but not on ducts (27). Thus, from pharmacological studies,
it seems that exocrine glands can express receptors belonging to P2X
and P2Y families, but their identity, localization, and function are unclear.
Pancreatic ducts modify enzyme- and Cl -rich
secretion originating from acini by adding a bicarbonate-rich fluid.
Bicarbonate secretion is achieved by coupling of ion transport through
the luminal cystic fibrosis transmembrane regulator Cl
channels and the luminal
Cl /HCO3 exchanger
(28-30). The driving force for the Cl exit is kept by
the K+ exit via the basolateral K+ channels
(29, 31-33). The main regulators of pancreatic bicarbonate secretion
are secretin, vasoactive intestinal peptide, acetylcholine, and
noradrenaline (30, 34, 35). In earlier studies, we showed that isolated
ducts also respond to ATP by releasing stored Ca2+ and
initiating Ca2+ influx through channels different from
those used by acetylcholine (36-38). Furthermore, we demonstrated that
ATP inhibits secretin-evoked changes in the membrane voltage (37). We
used Ca2+ signals and pharmacological profiles to describe
two types of receptors: one responding to UTP and ATP and belonging to
the P2Y superfamily (P2Y2-like receptor) and another
responding to BzATP1 and ATP
and belonging to the P2X superfamily (P2X7-like
receptor) (36). Although epithelial P2 receptors are associated with
Ca2+ signaling in ducts, it is not clear how this is
further translated into ion transport and thus secretion in native
pancreatic ducts. Therefore, the aim of this study was to use the
patch-clamp methods and intracellular Ca2+ measurements to
elucidate how purinergic receptors regulate ion transport in pancreatic
ducts. Furthermore, we aimed at identifying these purinoceptors using
molecular biological methods, which were applied to this epithelium for
the first time. For this purpose, we used pancreatic duct fragments
prepared from collagenase digests of whole rat pancreas. The advantage
of this preparation is that we can obtain pure duct cells free of the
surrounding connective tissue, blood vessels, and nerves, all likely
purinoceptor contaminants. These ducts retain receptors,
Ca2+ signals, and electrophysiological responses comparable
to the microdissected ducts (29, 30, 32, 34, 39). The disadvantage of
the preparation is that ducts are too fragile for microperfusion; and
thus, the polarity of the responses cannot be studied.
In this study, we show that UTP/ATP inhibit K+ channels and
thus most likely cannot support secretion. On the other hand, BzATP stimulates cation conductance and may therefore regulate secretory processes stimulated by other secretagogues. RT-PCR analysis revealed that ducts contain mRNAs for P2Y2 and P2X7
receptors, likely candidates for the observed effects, as well as
mRNAs for P2Y4 and P2X4 receptors.
 |
EXPERIMENTAL PROCEDURES |
Materials--
All standard chemicals including collagenase V,
trypsin inhibitor, UTP, ATP, and BzATP were obtained from Sigma
(Copenhagen, Denmark). Fura-2/AM and BCECF/AM were obtained from
Molecular Probes, Inc. (Leiden, The Netherlands). Tissue culture media
and primers for PCR were provided by Life Technologies, Inc.
Preparation of Ducts--
Female Wistar rats (100-200 g), kept
on a standard laboratory diet, were killed by cervical dislocation. The
pancreas was excised and subjected to collagenase digestion as
described previously (39). Briefly, the pancreas was cut into small
pieces and incubated with collagenase V (1.3 mg/ml) in Dulbecco's
modified Eagle medium 1000/Ham's F-12 mixture containing trypsin
inhibitor (0.17 mg/ml). Pancreatic ducts compose <5% of the total
pancreatic tissue, and single intercalated and small intralobular duct
fragments (outer diameter of 10-40 µm and length of 100-200 µm)
were identified with the aid of a dissection microscope. Any remaining
loose connective tissue and small blood vessels were stripped with
sharpened forceps. Subsequently, ducts were transferred into a chamber
placed on an inverted microscope (Axiovert 100TV (Carl Zeiss, Inc.) or
DM IRBE (Leica Inc.)) and inspected with 40× or 63× objectives for "cleanliness." Fig. 1 shows an
example of small intralobular ducts obtained using these methods. These
"clean" ducts were used for patch-clamp experiments, for molecular
biology, and for most fluorescence measurements. For physiological
experiments, suction pipettes held ducts on a side such that both the
luminal and basolateral sides of the epithelium were accessible to the
bathing solutions. For one series of experiments, small intralobular
and extralobular ducts (outer diameter of 20-50 µm) were
microdissected from fresh rat pancreas. These microdissected ducts were
held between concentric pipettes at each end, and the lumen was
perfused according to methods described earlier (32). Such ducts were
used for microelectrode recordings.

View larger version (72K):
[in this window]
[in a new window]
|
Fig. 1.
Pancreatic ducts. Shown is an example of
two pancreatic ducts freed from the surrounding connective tissue by
collagenase digestion and microdissection. Both ducts are intralobular;
the duct in the right panel is closest to acinar cells.
Bars indicate 20 µm. Differential contrast images were
obtained with a 63× water objective in a Leica confocal laser scanning
microscope.
|
|
During all physiological experiments, the chamber was continuously
perfused at a rate of 10-15 ml/min to avoid mechanical disturbances,
which can cause release of
ATP.2 Control solutions
contained 145 mM Na+, 3.6 mM
K+, 1.5 mM Ca2+, 1 mM
Mg2+, 125 mM Cl , 25 mM HCO3 , 2 mM
phosphate, and 5 mM glucose. The pH was equilibrated to 7.4 with 5% CO2 in O2. The temperature was kept
constant at 37 °C during all experiments. In some experiments,
K+, Na+, or Cl concentrations
were modified as follows: K+ was increased from 3.6 to 20, 25, or 50 mM by equimolar substitution for Na+;
Na+ was decreased from 145 to 5 mM and
substituted with N-methyl-D-glucamine; and
Cl was decreased from 125 to 5 mM and
substituted with gluconate. The pancreatic ducts were stimulated with
ATP, UTP, and BzATP in concentrations of 0.1 mM. In a few
experiments, concentrations of agonists were varied from
10 8 to 10 3 M, except for BzATP,
which was not used at concentrations higher than 0.1 mM due
to the cost.
Electrophysiological Measurements--
The cell responses to
nucleotides were monitored in whole-cell nystatin patch-clamp
recordings adopted for pancreatic ducts (39). Patch pipettes had
resistances of 3-5 megaohms, and the initial seal was at least 1 gigaohm. The success rate of obtaining seals was <10%, and stable
cell membrane voltage recordings were obtained only in a fraction of
these. The cell membrane under the pipette was permeabilized to make
direct electrical access to duct cells. Nystatin (0.02-0.1
mM) was dissolved in a pipette solution adjusted to pH 7.2 that had the following composition: 11 mM Na+,
125 mM K+, 32 mM Cl ,
96 mM gluconate, 1 mM Mg2+, 6 mM phosphate, and 5 mM glucose; and
Ca2+ was adjusted to 0.1 µM with EGTA. A
flowing 1 M KCl electrode was used as a reference. The
membrane voltage (Vm) was continuously monitored during
experiments in a current-clamp mode (zero current clamp). Periodically,
the whole-cell current (I) was measured in a voltage-clamp
mode, where the voltage was first clamped to the spontaneous cell
voltage and then in increasing and decreasing 10-mV steps of 500-ms
duration. In some experiments, Vm was clamped at the
spontaneous cell voltage, and continuous whole-cell currents were
measured. Where possible, the total conductance (Gt)
was corrected for the series resistance to obtain the cell membrane
conductance. The series resistance was estimated by the compensation
circuit of the patch-clamp amplifier (EPC 9, Heka, Lambrecht, Germany),
and in some cases where this was not possible, series resistance and
cell membrane conductance estimations were made subsequently by fitting
an exponential function to the initial part of the current trace (40).
Since duct cells can be variably coupled to each other,
Gt changes with the agonists are relative rather
than absolute. In several experiments, ducts were microdissected and
microperfused according to methods described earlier (32). Single duct
cells were impaled with 100-200-megaohm Ling-Gerard microelectrodes,
and Vm was recorded with a WPI electrometer.
Measurements of Intracellular Ca2+ and Intracellular
pH--
The fura-2 method was used to estimate
[Ca2+]i in pancreatic ducts. Briefly, as we have
described earlier (37), ducts were loaded with 0.5-1.0
µM fura-2/AM, and the fluorescence intensity of 10-20
cells was measured with a photomultipler at 510 nm after excitation at
340, 360, and 380 nm. The fluorescence ratio (340/380 nm) was an
estimate of [Ca2+]i. Signals were calibrated
in situ with ionomycin (1.0-5.0 µM). For
pHi measurements, ducts were loaded with BCECF/AM as described
earlier (41). Emission intensity of duct cells was measured at 510 nm
after excitation at 490 and 440 nm. The fluorescence ratio (490/440 nm)
was an estimate of pHi. Signals were calibrated in
situ with the protonophore carbonyl cyanide
p-chlorophenylhydrazone or nigericin (1 or 10 µM).
Statistics--
Physiological data are presented as original
recordings, summaries, and means ± S.E. In most experiments,
control and test measurements were made within one duct cell or one
duct, and n refers to measurements on different ducts. The
paired Student's t test was applied, and p < 0.05 was accepted as significant. The F-test was used to test for
the difference between two regression coefficients obtained for the
current-voltage relations.
RNA Isolation, cDNA Synthesis, and Polymerase Chain Reaction
Amplification--
Total RNA was isolated from small pancreatic ducts
(prepared from collagenase digests of rat pancreas) (Fig. 1) using
total RNA isolation reagent (Advanced Biotechnologies Ltd.) according to the manufacturer's instructions. First strand cDNA was
synthesized utilizing an anchored oligo(dT) primer using Reverse-iT
(Advanced Biotechnologies Ltd.). PCR conditions were identical for all
primers (Table I). 2 µl of
reverse-transcribed RNA was added to a solution of 10 µM
each forward and reverse primers, 1.5 mM MgCl2,
PCR buffer (7.5 mM Tris-HCl, pH 8.8, 20 mM
(NH4)2SO4, and 0.01% (v/v) Tween 20), 0.5 mM dNTPs, 1.25 units of Red Hot DNA polymerase
(all from Advanced Biotechnologies Ltd.), and distilled H2O
in a total volume of 50 µl. Temperature cycling proceeded as follows:
1 cycle at 94 °C for 5 min and 35 cycles at 94 °C for 30 s,
55 °C for 60 s, and 72 °C for 90 s, followed by
72 °C for 10 min. PCR products were then subjected to gel
electrophoresis on a 1% agarose gel containing ethidium bromide.
Possible contamination of blood vessels and acinar cells was ruled out
by RT-PCR amplification of thrombin and amylase using two specific
primers (Table I). Thrombin is present in endothelial cells, but not
duct cells; and similarly, amylase is present in acinar cells, but not
duct cells. As a positive control for duct cells, carbonic anhydrase II
primers were used. As tissue controls, we used blood vessels obtained
from collagenase digests of pancreas as well as the whole pancreas and
testis.
View this table:
[in this window]
[in a new window]
|
Table I
Primers used for RT-PCR on total RNA from pancreatic ducts
The following primers were used in RT-PCR on total RNA from pancreatic
duct cells.
|
|
 |
RESULTS |
Effect of Nucleotides on Cell Calcium--
Fig.
2A shows the effect of
extracellular ATP and BzATP (0.1 mM) on
[Ca2+]i in pancreatic ducts. ATP stimulation,
similar to that of acetylcholine, evokes a characteristic biphasic
Ca2+ response consisting of a Ca2+ peak and a
Ca2+ plateau. The peak response is largely due to release
of Ca2+ from intracellular stores, whereas the plateau
reflects largely influx of Ca2+ from extracellular medium
(36, 38). UTP evoked a similar response, but a more pronounced
Ca2+ influx component. On the other hand, stimulation with
BzATP led to a monophasic Ca2+ response, which was almost
fully dependent on extracellular Ca2+ and thus due to
Ca2+ influx. On the basis of these and other observations,
we postulated that there are at least two types of receptors belonging
to both P2Y and P2X families (36). Fig. 2B summarizes the
maximal Ca2+ responses for the three purinergic analogues
used in this study. The EC50 values for UTP, ATP, and BzATP
were estimated at 5, 4, and ~20 µM, respectively. ATP,
UTP, and BzATP were the best agonists regarding the intracellular
Ca2+ signals compared with ITP, 2-methylthio-ATP,
, -methylene-ATP, and adenosine, as shown earlier (36). Since
native pancreatic ducts are not suitable for extensive
electrophysiological experiments (see "Experimental Procedures"),
we focused on using ATP, UTP, and BzATP as pharmacological markers for
further patch-clamp experiments aimed at elucidating how purinoceptors
couple to ion transport.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of UTP, ATP, and BzATP on
intracellular Ca2+. A, effect of agonists (0.1 mM) on Ca2+ transients in a single duct;
B, concentration-response curves for ATP, UTP, and BzATP.
Responses are given as changes in the fluorescence ratio 340/380 nm.
Each point is a mean ± S.E. for 3-11 experiments.
|
|
Effect of UTP and ATP on Cell Membrane Voltage and
Conductance--
In contrast to the Ca2+ responses evoked
by UTP and ATP, the Vm responses measured in whole-cell
patch-clamp experiments were relatively small, although there was some
variability between cells. On average, UTP and ATP evoked ~10-mV
changes in Vm, and in several cells, the effects were very
small, as shown in an original recording in Fig.
3A. In contrast, BzATP
depolarized Vm reversibly by ~20 mV in the same cell. Fig.
3B shows a whole-cell current measurement in another duct
cell, where again the ATP and UTP responses were small, whereas BzATP
stimulated a sustained inward current of ~100 pA at a holding
potential of 60 mV. In this experiment, carried out in a
current-clamp mode, ATP depolarized Vm by 9 mV, and UTP by 4 mV
(not shown). Similar paired experiments were performed on 14 ducts, and
Fig. 4A shows the summary of
the Vm data for the three agonists. The summary shows that UTP
and ATP caused small but significant Vm depolarizations of
8 ± 2 and 10 ± 2 mV, respectively. BzATP depolarized
Vm by 22 ± 3 mV in the same experiments, and this effect
was significantly larger compared with the UTP and ATP responses
(p < 0.005).

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of ATP, UTP, and BzATP on membrane
voltage and current in single duct cells. A, original
recording of Vm in a duct cell stimulated with 0.1 mM nucleotides. For most of the time, a spontaneous
Vm was recorded (zero current clamp), except for short
intervals when Vm was clamped in 10-mV steps above and below
the spontaneous Vm for the whole-cell current measurements.
B, recording of the whole-cell current in another duct cell
where Vm was clamped at 60 mV.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
Nucleotides depolarize membrane voltage but
have different effects on the total conductance. The effects of
nucleotides on Vm and Gt are summarized for
13-14 experiments. Protocols are the same as described in the legend
of Fig. 3; and in most cases, all three nucleotides were tested on each
duct. A, individual experiments are depicted in the
upper panel showing control values for Vm just prior
to and after the application of nucleotides and the Vm values
with UTP, ATP, and BzATP (0.1 mM). The mean Vm
changes ± S.E. for each nucleotide are summarized in the
lower panel. B, shown is a summary of the mean
Gt changes ± S.E. obtained from the
I/V relations in these experiments.
Asterisks indicate that the test values for nucleotides were
significantly different from their corresponding controls (*,
p < 0.05; **, p < 0.005; ***,
p < 0.0005). nS, nanosiemens.
|
|
In the next series of experiments, we investigated the
electrophysiological events underlying the Vm depolarization caused by UTP and ATP. To illustrate how Vm changes correlate with the cell conductance changes, Fig.
5A shows an experiment in
which the Vm responses to UTP and ATP were some of the largest
obtained. The corresponding current-voltage relations in Fig.
5B show that during the UTP and ATP stimulation, Vm shifted away from the resting voltage; but notably,
Gt decreased. A summary of the whole-cell
conductance data for 14 experiments is given in Fig. 4B. UTP
and ATP caused small but significant reductions in
Gt of 17 and 20%, whereas BzATP increased
Gt by 18%. In 10 of these experiments, where it was
possible to correct Gt for series resistance, changes in the cell membrane conductance evoked by UTP, ATP, and BzATP
were qualitatively and quantitatively similar.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 5.
UTP and ATP depolarize Vm and
decrease Gt. A, original recording of
Vm and the corresponding current in a duct cell stimulated with
0.1 mM UTP and ATP. Except for the voltage-clamp protocols,
spontaneous Vm was recorded. A decrease in the current response
in voltage-clamp protocols during the agonist application indicates a
decrease in Gt. B,
I/V relation obtained from the voltage-clamp
protocols shown above for the same cell.
|
|
The depolarization of Vm and the reduction in whole-cell
conductance, triggered by UTP and ATP, could be due to a closure of
K+ channels. This theory was tested in current-clamp
experiments in which the bath K+ concentration was changed
from 4 to 20 mM (see "Experimental Procedures"). In
unstimulated ducts, this K+ concentration change resulted
in ~20-mV depolarization of Vm, as shown in the original
recordings in Fig. 6A. During
the ATP stimulation, however, the same K+ concentration
step had a smaller effect, depolarizing Vm by ~10 mV. Fig.
6B summarizes seven paired experiments with similar protocols in unstimulated and UTP/ATP-stimulated ducts. Thus, in the
stimulated ducts, the K+ concentration step depolarized
Vm by 13 ± 3 mV. In the same but unstimulated ducts, the
K+ step depolarized Vm significantly more by
19 ± 1 mV (p < 0.05). In additional experiments,
duct cells were voltage-clamped in bath solution containing 4, 25, or
50 mM K+ in the presence or absence of UTP or
ATP. An example of such a paired experiment on one duct cell is shown
in Fig. 6 (C and D). At 4 mM
K+, UTP decreased Gt from 10.8 to 5.8 nanosiemens (p < 0.001) and shifted the reversal
potential by 16 mV away from the K+ equilibrium potential
(Fig. 6C). At 25 and 50 mM K+ (only
50 mM K+ is shown in Fig. 6D), the
control Gt was higher compared with 4 mM
K +, as expected for K+ currents. UTP decreased
Gt from 25.3 to 16.0 nanosiemens (p < 0.001), but the reversal potential was not affected as the cell
voltage lies close to the equilibrium potentials for K+,
Cl , and nonspecific cation conductance. Similar paired
observations were obtained for an additional four cells.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 6.
ATP and UTP inhibit K+
conductance. A, effect of a K+
concentration step (from 4 to 20 (K20) mM) on
the Vm of a single duct cell unstimulated and stimulated with
0.1 mM ATP. B, summary of data shown as
means ± S.E. for seven such experiments in which duct cells were
stimulated with ATP or UTP and the Vm response to the 20 mM K+ step was compared with that in the same
unstimulated cells. Asterisks indicate that the test values
for the K+ step were significantly different from the
control resting Vm (**, p < 0.005; ***,
p < 0.0005), and the response to 20 mM
K+ was significantly smaller in stimulated
versus unstimulated duct cells (p < 0.05).
C and D, I/V curves for one
cell exposed to 4 (K4) or 50 (K50)
mM K+ solution, respectively, in the presence
or absence of UTP (0.1 mM). The whole-cell currents were
dominated by the K+ conductance, which was inhibited by
UTP.
|
|
Effect of ATP on Intracellular pH--
Taken together, UTP/ATP
depolarize Vm due to closure of K+ channels. One
candidate for the K+ channel, the renal K+
channel (see "Discussion"), is down-regulated by intracellular Ca2+ and acidic pHi. Therefore, in a separate set
of experiments, we monitored pHi in duct cells loaded with
BCECF in response to ATP. Fig. 7 shows
the reversible effect of ATP (0.1 mM) on the pHi of
a pancreatic duct. For comparison, this figure also shows the
pHi of another duct stimulated with a classical duct
secretagogue, secretin (1 nM). In summary, ATP decreased
pHi from 7.51 ± 0.08 to 7.40 ± 0.10 in eight ducts
(p < 0.005). In contrast, secretin had no effect on
pHi in similar experiments, i.e. pHi was
7.49 ± 0.05 in resting ducts and 7.50 ± 0.05 in stimulated
ducts (n = 16).

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 7.
ATP decreases pHi. Shown is the
effect of extracellular ATP (0.1 mM) on pHi in one
pancreatic duct. For comparison, this original recording shows the
effect of secretin (1 nM) on pHi recorded in
another pancreatic duct.
|
|
Effect of BzATP on Cell Membrane Voltage and Conductance--
In
another series of experiments, we investigated the ionic basis for
BzATP-evoked depolarization in Vm and increased whole-cell
conductance. Fig. 8 shows examples of two
protocols carried out in four experiments. Fig. 8A is the
original recording of whole-cell currents in a duct stimulated with
BzATP in a control 145 mM Na+ solution and in a
test 5 mM Na+ solution. Fig. 8B
shows the results of a voltage-clamp protocol carried out on another
cell stimulated with BzATP in control and low Na+
solutions. The current-voltage relation indicates that BzATP increases
the whole-cell conductance, but only in the presence of control
Na+ concentrations. Hence, these experiments show that
BzATP opens cation channels that allow Na+ and also
Ca2+ influx, as shown earlier (36). In another set of
experiments (n = 4), we tested whether BzATP
stimulation affects the Cl conductance. Fig.
9 presents an example of one of four
experiments in which the bath Cl concentration was
decreased from 125 to 5 mM. This maneuver seemed to have no
effect on BzATP-evoked Vm changes, which indicates that the
Cl conductance was unaffected. For comparison, in ducts
stimulated with secretin or isoproterenol, a similar Cl
concentration step causes 15-20-mV depolarization, which is due to an
increase in the cystic fibrosis transmembrane regulator Cl conductance (30, 34).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 8.
BzATP increases inward current that is
dependent on extracellular Na+. A,
continuous recording of a whole-cell current in a duct cell stimulated
with 0.1 mM BzATP with 145 and 5 (5Na)
mM Na+ solutions as indicated by the
bars; B, I/V relation taken
from recordings made in another cell stimulated with BzATP with control
(145 mM Na+) and 5 mM
Na+ (5Na) in the extracellular medium. Increases
in the whole-cell conductance with BzATP were apparent only with high
extracellular Na+.
|
|

View larger version (8K):
[in this window]
[in a new window]
|
Fig. 9.
BzATP effect on Vm is independent of
extracellular Cl . Shown is a
continuous recording of Vm in a duct cell stimulated with 0.1 mM BzATP as indicated by the bar. Some minutes
later, the same cell was stimulated again, and extracellular
Cl was decreased from 125 to 5 mM
(5Cl).
|
|
Microelectrode Recordings on Perfused Ducts--
In one series of
experiments, the Vm of single duct cells was monitored with
microelectrodes on microperfused ducts obtained by microdissection, and
one such experiment is shown in Fig.
10A. ATP application from
the basolateral side led to a small depolarization of 2 ± 1 mV
(n = 8), sometimes preceded by a few millivolts of
hyperpolarization (also see Ref. 37). These Vm changes are very
similar to UTP/ATP responses observed using the whole-cell patch-clamp
recordings in duct fragments (Figs. 3-6). In contrast, luminal
application of ATP resulted in a significantly larger and reversible
depolarization of 17 ± 3 mV (n = 10). These
Vm changes were similar to the BzATP responses observed in duct
fragments (Figs. 3 and 4).

View larger version (9K):
[in this window]
[in a new window]
|
Fig. 10.
Luminal ATP has a bigger effect than
basolateral ATP on Vm. Shown is an original recording of
Vm taken with a microelectrode in a microperfused duct. ATP
(0.1 mM) was applied from the basolateral side (ATP
bl), or it was infused luminally (ATP lum) as indicated
by the bars. The recording also shows the effect of
basolateral 20 mM K+ (K20).
|
|
P2 Purinoceptor Subtype Expression in Pancreatic Duct Cells
Analyzed by RT-PCR--
Since the pharmacological data presented above
indicated the existence of both P2X and P2Y receptors, we used RT-PCR
to investigate which subtypes of the purinergic receptor were expressed
in ducts. As shown in Fig.
11A, by use of primers for
the P2X family (P2X1 to P2X7), we could detect
transcripts of both P2X4 and P2X7. There were
two bands for P2X7; the upper band was seen only when total RNA from pancreatic ducts was used, and not when RT-PCR was performed on total RNA from other tissues. Whether the upper band is due to
mispriming or to a yet unknown P2X receptor requires further investigations. Regarding the P2Y family of purinergic receptors, we
did not include primers for P2Y3, as the sequence available from GenBankTM is non-mammalian, or primers for
P2Y5 and P2Y7, as their identity as
purinoceptors is doubtful (1). In the case of the P2Y receptors, we
were able to detect transcripts of P2Y2 and
P2Y4, but not of P2Y6. As a control for duct
epithelium, we show expression of mRNA for carbonic anhydrase II.
The samples were free of RNA contaminants from acini and blood vessels
since no products for amylase and thrombin were detected. The primers
that gave no product in the ducts (P2X1, P2X2,
P2X3, P2X5, P2X6, P2Y1,
and P2Y6) were tested on total RNA from testis, blood
vessels, and whole pancreas to verify the ability of these primers to
give products (Fig. 11B).

View larger version (63K):
[in this window]
[in a new window]
|
Fig. 11.
P2 purinoceptor subtype expression in
pancreatic duct cells analyzed by RT-PCR. A, total RNA
from pancreatic duct cells was reverse-transcribed, and the resulting
cDNA was PCR-amplified using the indicated primers (see Table I).
Lane Mw contains molecular weight markers.
B, PCR primers that gave no signal in pancreatic ducts are
shown here as positive controls obtained from testis, blood vessels,
and whole pancreas. The gels shown are representative of at least three
independent experiments. CAII, carbonic anhydrase II.
|
|
 |
DISCUSSION |
The key observations are that UTP/ATP evoked large
Ca2+ signals, a small depolarization of the membrane
voltage, and a decrease in the whole-cell conductance, effects due to
an inhibition of K+ channels. BzATP/ATP increased cell
Ca2+ and caused a large depolarization of the membrane
voltage and an increase in the whole-cell membrane conductance, effects
due to opening of cation channels and influx of Na+ and
Ca2+. Thus, the two types of electrophysiological and
Ca2+ responses are due to at least two types of
purinoceptors in pancreatic ducts. RT-PCR analysis showed that native
pancreatic ducts possess mRNAs for P2Y2,
P2Y4, P2X4, and P2X7 purinoceptors.
These are the first molecular biological data on native pancreatic duct epithelium.
P2Y Receptors--
Recently, it became evident that pyrimidines
can exert their action via several P2Y purinoceptors (1). In expression
systems, the P2Y2 receptor is stimulated equally well with
UTP and ATP; the human P2Y4 receptor has a greater
selectivity for UTP over ATP; and the P2Y6 receptor is
stimulated preferentially with UDP (42, 44, 45). In pancreatic ducts,
we did not find expression of mRNA for P2Y6, which is
the luminal receptor on respiratory and intestinal epithelia
responsible for Ca2+-mediated Cl secretion
(12, 13). However, we detected transcripts for both P2Y2
and P2Y4 receptors (Fig. 11). Unfortunately, rat
P2Y2 and P2Y4 receptors show similar
pharmacology regarding agonists and accept ATP and UTP equally well
(46). Both cell Ca2+ and electrophysiological responses are
slightly more pronounced with UTP compared with ATP. However, this may
simply be due to the ability of ATP to cross-react with the second type
of receptors (P2X) discussed below. Thus, we cannot on this basis
conclude which receptor is associated with the physiological response
we observed in rat ducts. Nevertheless, stimulation of
P2Y2/P2Y4 leads to a large Ca2+
transient and inhibition of K+ channels (Figs. 4-6). The
inhibition of K+ channels is an unexpected finding, as in
many similar epithelia, including cultured human and dog pancreatic
duct epithelia (see the Introduction), P2Y2-like receptors
stimulate K+ fluxes as well as Cl fluxes (2,
3, 7, 10, 47). Some differences between our results and these data may
be accounted for by different experimental conditions, as mentioned in
the Introduction, or by different transport properties of epithelia
derived from small intralobular ducts compared with main/large
pancreatic ducts used for the tissue culture (48). Nonetheless, there
are a few recent reports indicating that P2Y2 receptors can
inhibit M-type K+ currents in neurons (49), IsK/KvLQT1
K+ channels in vestibular dark cells (50), and
Ca2+-activated K+ channels in spermatogenic
cells (51). It is not yet clear what cellular mechanisms cause, on one
hand, an increase in cell Ca2+ and, on the other hand, an
inhibition of K+ channels. Inhibitory mechanisms could be
indirect, involving calmodulin II, protein kinase C, or membrane-bound
phosphatases; or they could be directly exerted by intracellular
Ca2+, e.g. the eag K+
channel and renal K+ channels, or by acidic pHi
(52-56). Our earlier studies on ducts show that the major cell
K+ conductance resides on the basolateral as opposed to the
luminal membrane (32, 33); but except for a few patch-clamp studies on
pancreatic ducts (31, 57), the identity of K+ channels is
unknown. However, from our earlier studies, we know that the
basolateral K+ channels are inhibited by acidic
pHi; and consequently, ducts cannot secrete (33).
Interestingly, in this study, we have shown that ATP actually decreases
pHi (Fig. 7). Thus, a fall in pHi or changes in cell
Ca2+ and associated messengers could close the
K+ channels in pancreatic ducts. Given that
P2Y2/P2Y4 receptors inhibit K+
channels in pancreatic duct cells, they cannot support secretion, as
Cl efflux cannot be followed by K+ efflux
(see the Introduction). Perhaps then P2Y2/Y4
receptors could be involved in a down-regulation of secretion evoked by the true secretagogues.
P2X Receptors--
In our recent study, we identified the
BzATP-responsive receptor pharmacologically as the P2Z
(P2X7-like) receptor (36). BzATP or high ATP levels evoked
Ca2+ transients resulting from a Ca2+ influx,
which was sensitive to DIDS, Mg2+, La3+, and
extracellular pH (36, 38). This study shows that BzATP activates an
inward Na+ current, supporting the idea that this is a
ligand-gated receptor. The P2Z receptor would in many cases correspond
to the cloned P2X7 receptor (58). Since we also found
transcripts for the P2X7 receptor in pancreatic ducts, the
simplest interpretation is that the P2Z receptors we have described
earlier are also of this type. However, the receptor does not form a
pore either in our preparation or in other exocrine glands (4, 11, 17, 19-23, 26), as it does in immunoreactive cells. One possibility is
that the P2X7 receptor expressed in glands does not contain the carboxyl-terminal domain necessary for the pore formation (58).
Another possibility is that our cells do not express ancillary factors
necessary for the P2X7 pore formation. This possibility is
not remote, as the P2X7-associated pore formation depends
on the expression system (59). Finally, P2X receptors are two
transmembrane-spanning proteins that can form heteromers,
e.g. P2X2 and P2X3 (60); and given
the expression of P2X4 in ducts, it is possible to
speculate that the P2X4 and P2X7 proteins could
form heteromers responsible for the physiological properties we
observed in glands. Nevertheless, we cannot exclude that the
P2X4 homomer could also be responsible for some of the
characteristics we observed. This receptor displays a higher affinity
for ATP than P2X7 (43, 61, 62), consistent with the
observed effects on Ca2+ transients (Fig. 2). However,
since ATP also cross-reacts with the P2Y receptors described above, one
cannot use the EC50 values conclusively. Nevertheless, the
lower sensitivity of P2X4 to DIDS and , -methylene-ATP
(43, 62) compared with the sensitivity we observed (36) indicates that
the P2X7 response may be dominant.
The present finding that the stimulation of the P2X7
receptor is associated with increased Na+/Ca2+
conductance is in agreement with earlier findings on salivary gland and
lacrimal gland acini, which express the P2X7-like receptors (17, 19-23, 26). Moreover, in these glands, ATP also increases protein
secretion, cell volume changes, and ion fluxes, all indicative of
secretory activity. With respect to pancreatic ducts, if the P2X7 receptors increase only the
Na+/Ca2+ conductance, it is difficult to
envisage how this could support secretion. Clearly, there must be an
opening of the luminal Cl channels and the basolateral
K+ channels as well as activation of exchangers, as
observed with true secretagogues (30, 33). Therefore, on the basis of
the present data, this receptor on its own could probably not evoke secretion; rather, by virtue of its effect on Ca2+, it
could regulate secretion evoked by other secretagogues. Since, in the
perfused duct, ATP had the strongest effects on the lumen, reminiscent
of those BzATP had on the duct fragments, the most likely localization
of the P2X7 receptor is on the luminal membrane. In another
type of ductal epithelium, namely ducts from submandibular glands, the
luminal P2X7-like receptor seems to have the unusual effect
of opening Cl channels, without reported effects on the
cation conductances (4, 11). One interpretation is that salivary gland
ducts do not secrete fluid as do pancreatic ducts; and thus, coupling of receptors and transporters may be different.
In conclusion, our studies demonstrate that native pancreatic ducts
express mRNAs for P2Y2 and P2Y4 receptors
as well as for P2X4 and P2X7 receptors.
Stimulation of P2Y2 (and possibly P2Y4) receptors leads to an increase in cell Ca2+, but a decrease
in cell K+ conductance, a process that is not compatible
with secretion. Thus, UTP/ATP acting on these receptors would
down-regulate secretion evoked by other secretagogues. In contrast,
stimulation of P2X7 (and possibly P2X4)
receptors is associated with increased cation conductance, a process
that may modulate action of other secretagogues.
 |
Note Added in Proof |
After acceptance of our paper, Luo and
co-workers published an article (Luo, X., Zheng, W., Yan, M., Lee, M. G., and Muallem, S. (1999) Am. J. Physiol. 277, C205-C215) showing a greater variety of P2X and P2Y receptors in
pancreatic tissue. Differences between these and our results may be due
to purity of duct tissue used for RT-PCR.
 |
FOOTNOTES |
*
This work was supported by the Danish Natural Science
Research Council, the Novo-Nordisk Research Foundation, and the
Carlsberg Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence and reprint requests should be addressed.
Tel.: 45-3532-1645; Fax: 45-3532-1567; E-mail: inovak@aki.ku.dk.
2
C. E. Neumann and I. Novak, unpublished observations.
 |
ABBREVIATIONS |
The abbreviations used are:
BzATP, 2',3'-O-4-benzoylbenzoyl-ATP;
RT-PCR, reverse
transcription-polymerase chain reaction;
BCECF, 2',7'-bis(carboxyethyl)-5(6)-carboxyfluorescein;
Vm, membrane
voltage;
Gt, total whole-cell conductance;
DIDS, 4,4'-diisothiocyanatostilbene-2,2'-disulfonic acid.
 |
REFERENCES |
| 1.
|
Ralevic, V.,
and Burnstock, G.
(1998)
Pharmacol. Rev.
50,
413-492[Abstract/Free Full Text]
|
| 2.
|
Chan, H. C.,
Cheung, W. T.,
Leung, P. Y.,
Wu, L. J.,
Chew, S. B.,
Ko, W. H.,
and Wong, P. Y.
(1996)
Am. J. Physiol.
271,
C469-C477[Abstract/Free Full Text]
|
| 3.
|
Cheung, C. Y.,
Wang, X. F.,
and Chan, H. C.
(1998)
Biol. Signals Recept.
7,
321-327[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Lee, M. G.,
Zeng, W.,
and Muallem, S.
(1997)
J. Biol. Chem.
272,
32951-32955[Abstract/Free Full Text]
|
| 5.
|
Leipziger, J.,
Nitschke, R.,
and Greger, R.
(1991)
Cell. Physiol. Biochem.
1,
273-285
|
| 6.
|
Mason, S. J.,
Paradiso, A. M.,
and Boucher, R. C.
(1991)
Br. J. Pharmacol.
103,
1649-1656[Medline]
[Order article via Infotrieve]
|
| 7.
|
Nguyen, T. D.,
Moody, M. W.,
Savard, C. E.,
and Lee, S. P.
(1998)
Am. J. Physiol.
275,
G104-G113[Abstract/Free Full Text]
|
| 8.
|
Parr, C. E.,
Sullivan, D. M.,
Paradiso, A. M.,
Lazarowski, E. R.,
Burch, L. H.,
Olsen, J. C.,
Erb, L.,
Weisman, G.,
Boucher, R. C.,
and Turner, J. T.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
3275-3279[Abstract/Free Full Text]
|
| 9.
|
Stutts, M. J.,
Chinet, T. C.,
Mason, S. J.,
Fullton, J. M.,
Clarke, L. L.,
and Boucher, R. C.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
1621-1625[Abstract/Free Full Text]
|
| 10.
|
Warth, R.,
and Greger, R.
(1993)
Cell. Physiol. Biochem.
3,
2-16
|
| 11.
|
Zeng, W.,
Lee, M. G.,
and Muallem, S.
(1997)
J. Biol. Chem.
272,
32956-32965[Abstract/Free Full Text]
|
| 12.
|
Inoue, C. N.,
Woo, J. S.,
Schwiebert, E. M.,
Morita, T.,
Hanaoka, K.,
Guggino, S. E.,
and Guggino, W. B.
(1997)
Am. J. Physiol.
272,
C1862-C1870[Abstract/Free Full Text]
|
| 13.
|
Lazarowski, E. R.,
Paradiso, A. M.,
Watt, W. C.,
Harden, T. K.,
and Boucher, R. C.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
2599-2603[Abstract/Free Full Text]
|
| 14.
|
Turner, J. T.,
Weisman, G. A.,
and Camden, J. M.
(1997)
Am. J. Physiol.
273,
C1100-C1107[Abstract/Free Full Text]
|
| 15.
|
Park, M. K.,
Garrad, R. C.,
Weisman, G. A.,
and Turner, J. T.
(1997)
Am. J. Physiol.
272,
C1388-C1393[Abstract/Free Full Text]
|
| 16.
|
Amsallem, H.,
Métioui, M.,
and Van den Abeele, A.
(1996)
Am. J. Physiol.
271,
C1546-C1555[Abstract/Free Full Text]
|
| 17.
|
Métioui, M.,
Amsallem, H.,
Alzola, E.,
Chaib, N.,
Elyamani, A.,
Moran, A.,
Marino, A.,
and Dehaye, J. P.
(1996)
J. Cell. Physiol.
168,
462-475[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Gromada, J.,
Jørgensen, T. D.,
and Dissing, S.
(1995)
Pfluegers Arch. Eur. J. Physiol.
429,
578-586[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
McMillian, M. K.,
Soltoff, S. P.,
Lechleiter, J. D.,
Cantley, L. C.,
and Talamo, B. R.
(1988)
Biochem. J.
255,
291-300[Medline]
[Order article via Infotrieve]
|
| 20.
|
Sasaki, T.,
and Gallacher, D. V.
(1990)
FEBS Lett.
264,
130-134[CrossRef][Medline]
[Order article via Infotrieve]
|
| 21.
|
Soltoff, S. P.,
McMillian, M. K.,
Cragoe, E. J. J.,
Cantley, L. C.,
and Talamo, B. R.
(1990)
J. Gen. Physiol.
95,
319-346[Abstract/Free Full Text]
|
| 22.
|
Soltoff, S. P.,
McMillan, M. K.,
and Talamo, B. R.
(1992)
Am. J. Physiol.
262,
C934-C940[Abstract/Free Full Text]
|
| 23.
|
Vincent, P.
(1992)
J. Physiol. (Lond.)
449,
313-331[Abstract/Free Full Text]
|
| 24.
|
Alzola, E.,
Perez-Etxebarria, A.,
Kabre, E.,
Fogarty, D. J.,
Metioui, M.,
Chaib, N.,
Macarulla, J. M.,
Matute, C.,
Dehaye, J. P.,
and Marino, A.
(1998)
J. Biol. Chem.
273,
30208-30217[Abstract/Free Full Text]
|
| 25.
|
Hurley, T. W.,
Shoemaker, D. D.,
and Ryan, M. P.
(1993)
Am. J. Physiol.
265,
C1472-C1478[Abstract/Free Full Text]
|
| 26.
|
Jørgensen, T. D.,
Gromada, J.,
Tritsaris, K.,
Nauntofte, B.,
and Dissing, S.
(1995)
Biochem. J.
312,
457-464
|
| 27.
|
Buell, G.,
Lewis, C.,
Collo, G.,
North, R. A.,
and Surprenant, A.
(1996)
EMBO J.
15,
55-62[Medline]
[Order article via Infotrieve]
|
| 28.
|
Gray, M. A.,
Greenwell, J. R.,
and Argent, B. E.
(1988)
J. Membr. Biol.
105,
131-142[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Novak, I.,
and Greger, R.
(1988)
Pfluegers Arch. Eur. J. Physiol.
411,
546-553[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Novak, I.,
and Pahl, C.
(1993)
Pfluegers Arch. Eur. J. Physiol.
425,
272-279[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Gray, M. A.,
Greenwell, J. R.,
Garton, A. J.,
and Argent, B. E.
(1990)
J. Membr. Biol.
115,
203-215[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Novak, I.,
and Greger, R.
(1988)
Pfluegers Arch. Eur. J. Physiol.
411,
58-68[CrossRef][Medline]
[Order article via Infotrieve]
|
| 33.
|
Novak, I.,
and Greger, R.
(1991)
Pfluegers Arch. Eur. J. Physiol.
419,
76-83[CrossRef][Medline]
[Order article via Infotrieve]
|
| 34.
|
Novak, I.
(1998)
Gastroenterology
115,
1-9[CrossRef]
|
| 35.
|
Pahl, C.,
and Novak, I.
(1993)
Pfluegers Arch. Eur. J. Physiol.
424,
315-320[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Christoffersen, B. C.,
Hug, M. J.,
and Novak, I.
(1998)
Pfluegers Arch. Eur. J. Physiol.
436,
33-39[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Hug, M.,
Pahl, C.,
and Novak, I.
(1994)
Pfluegers Arch. Eur. J. Physiol.
426,
412-418[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Hug, M.,
Pahl, C.,
and Novak, I.
(1996)
Pfluegers Arch. Eur. J. Physiol.
432,
278-285[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Novak, I.,
and Hug, M. J.
(1995)
Cell. Physiol. Biochem.
5,
344-352
|
| 40.
|
Ogden, D. C.,
and Stanfield, P. R.
(1994)
in
Microelectrode Techniques
(Ogden, D., ed)
, pp. 63-81, Company of Biologists Ltd., Cambridge, United Kingdom
|
| 41.
|
Novak, I.,
Hug, M.,
and Greger, R.
(1997)
Comp. Biochem. Physiol. A Comp. Physiol.
118,
409-411[Medline]
[Order article via Infotrieve]
|
| 42.
|
Communi, D.,
Parmentier, M.,
and Boeynaems, J. M.
(1996)
Biochem. Biophys. Res. Commun.
222,
303-308[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Wang, C. Z.,
Namba, N.,
Gonoi, T.,
Inagaki, N.,
and Seino, S.
(1996)
Biochem. Biophys. Res. Commun.
220,
196-202[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Lustig, K. D.,
Shiau, A. K.,
Brake, A. J.,
and Julius, D.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
5113-5117[Abstract/Free Full Text]
|
| 45.
|
Nguyen, T.,
Erb, L.,
Weisman, G. A.,
Marchese, A.,
Heng, H. H. Q.,
Garrad, R. C.,
George, S. R.,
Turner, J. T.,
and O'Dowd, B. F.
(1995)
J. Biol. Chem.
270,
30845-30848[Abstract/Free Full Text]
|
| 46.
|
Bogdanov, Y. D.,
Wildman, S. S.,
Clements, M. P.,
King, B. F.,
and Burnstock, G.
(1998)
Br. J. Pharmacol.
124,
428-430[CrossRef][Medline]
[Order article via Infotrieve]
|
| 47.
|
Montserrat, C.,
Merten, M.,
and Figarella, C.
(1996)
FEBS Lett.
393,
264-268[CrossRef][Medline]
[Order article via Infotrieve]
|
| 48.
|
Novak, I.
(1988)
in
pH Homeostasis: Mechanism and Control
(Häussinger, D., ed)
, pp. 447-470, Academic Press Ltd., London
|
| 49.
|
Filippov, A. K.,
Webb, T. E.,
Barnard, E. A.,
and Brown, D. A.
(1998)
J. Neurosci.
18,
5170-5179[Abstract/Free Full Text]
|
| 50.
|
Marcus, D. C.,
Sunose, H.,
Liu, J.,
Shen, Z.,
and Scofield, M. A.
(1997)
Am. J. Physiol.
273,
C2022-C2029[Abstract/Free Full Text]
|
| 51.
|
Wu, W. L.,
So, S. C.,
Sun, Y. P.,
Chung, Y. W.,
Grima, J.,
Wong, P. Y.,
Yan, Y. C.,
and Chan, H. C.
(1998)
Biochem. Biophys. Res. Commun.
248,
728-732[CrossRef][Medline]
[Order article via Infotrieve]
|
| 52.
|
Bleich, M.,
Schlatter, E.,
and Greger, R.
(1990)
Pfluegers Arch. Eur. J. Physiol.
415,
449-460[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Kubokawa, M.,
McNicholas, C. M.,
Higgins, M. A.,
Wang, W.,
and Giebisch, G.
(1995)
Am. J. Physiol.
269,
F355-F362[Abstract/Free Full Text]
|
| 54.
|
Kubokawa, M.,
Wang, W.,
McNicholas, C. M.,
and Giebisch, G.
(1995)
Am. J. Physiol.
268,
F211-F219[Abstract/Free Full Text]
|
| 55.
|
McNicholas, C. M.,
Yang, Y.,
Giebisch, G.,
and Herbert, S. C.
(1996)
Am. J. Physiol.
271,
F275-F285[Abstract/Free Full Text]
|
| 56.
|
Stansfeld, C. E.,
Röper, J.,
Ludwig, J.,
Weseloh, R. M.,
Marsh, S. J.,
Brown, D. A.,
and Pongs, O.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
9910-9914[Abstract/Free Full Text]
|
| 57.
|
Novak, I.,
and Pahl, C.
(1993)
Pfluegers Arch. Eur. J. Physiol.
422,
R71 (abstr.)
|
| 58.
|
Surprenant, A.,
Rassendren, F.,
Kawashima, E.,
North, R. A.,
and Buell, G.
(1996)
Science
272,
735-738[Abstract]
|
| 59.
|
Petrou, S.,
Ugur, M.,
Drummond, R. M.,
Singer, J. J.,
and Walsh, J. V. J.
(1997)
FEBS Lett.
411,
339-345[CrossRef][Medline]
[Order article via Infotrieve]
|
| 60.
|
Lewis, C.,
Neidhart, S.,
Holy, C.,
North, R. A.,
Buell, G.,
and Surprenant, A.
(1995)
Nature
377,
432-435[CrossRef][Medline]
[Order article via Infotrieve]
|
| 61.
|
Garcia-Guzman, M.,
Soto, F.,
Gomez-Hernandez, J. M.,
Lund, P. E.,
and Stuhmer, W.
(1997)
Mol. Pharmacol.
51,
109-118[Abstract/Free Full Text]
|
| 62.
|
Soto, F.,
Garcia-Guzman, M.,
Gomez-Hernandez, J. M.,
Hollmann, M.,
Karschin, C.,
and Stuhmer, W.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
3684-3688[Abstract/Free Full Text]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. Heitzmann and R. Warth
Physiology and Pathophysiology of Potassium Channels in Gastrointestinal Epithelia
Physiol Rev,
July 1, 2008;
88(3):
1119 - 1182.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. R. Dubyak
Go It Alone No More P2X7 Joins the Society of Heteromeric ATP-Gated Receptor Channels
Mol. Pharmacol.,
December 1, 2007;
72(6):
1402 - 1405.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. Yegutkin, S. S. Samburski, S. Jalkanen, and I. Novak
ATP-consuming and ATP-generating Enzymes Secreted by Pancreas
J. Biol. Chem.,
October 6, 2006;
281(40):
29441 - 29447.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kittel, J. Pelletier, F. Bigonnesse, O. Guckelberger, K. Kordas, N. Braun, S. C. Robson, and J. Sevigny
Localization of Nucleoside Triphosphate Diphosphohydrolase-1 (NTPDase1) and NTPDase2 in Pancreas and Salivary Gland
J. Histochem. Cytochem.,
July 1, 2004;
52(7):
861 - 871.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. E. Bucheimer and J. Linden
Purinergic regulation of epithelial transport
J. Physiol.,
March 1, 2004;
555(2):
311 - 321.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Li, X. Luo, W. Zeng, and S. Muallem
Cell-specific Behavior of P2X7 Receptors in Mouse Parotid Acinar and Duct Cells
J. Biol. Chem.,
November 28, 2003;
278(48):
47554 - 47561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E Sorensen, J. Amstrup, H. N Rasmussen, I. Ankorina-Stark, and I. Novak
Rat pancreas secretes particulate ecto-nucleotidase CD39
J. Physiol.,
September 15, 2003;
551(3):
881 - 892.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Leipziger
Control of epithelial transport via luminal P2 receptors
Am J Physiol Renal Physiol,
March 1, 2003;
284(3):
F419 - F432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Novak
ATP as a Signaling Molecule: the Exocrine Focus
Physiology,
February 1, 2003;
18(1):
12 - 17.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Lehrmann, J. Thomas, S. J. Kim, C. Jacobi, and J. Leipziger
Luminal P2Y2 Receptor-Mediated Inhibition of Na+ Absorption in Isolated Perfused Mouse CCD
J. Am. Soc. Nephrol.,
January 1, 2002;
13(1):
10 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. A. BAILEY, M. IMBERT-TEBOUL, C. TURNER, S. K. SRAI, G. BURNSTOCK, and R. J. UNWIN
Evidence for Basolateral P2Y6 Receptors along the Rat Proximal Tubule: Functional and Molecular Characterization
J. Am. Soc. Nephrol.,
August 1, 2001;
12(8):
1640 - 1647.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. D. Nguyen, S. Meichle, U. S. Kim, T. Wong, and M. W. Moody
P2Y11, a purinergic receptor acting via cAMP, mediates secretion by pancreatic duct epithelial cells
Am J Physiol Gastrointest Liver Physiol,
May 1, 2001;
280(5):
G795 - G804.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. DEETJEN, J. THOMAS, H. LEHRMANN, S. J. KIM, and J. LEIPZIGER
The Luminal P2Y Receptor in the Isolated Perfused Mouse Cortical Collecting Duct
J. Am. Soc. Nephrol.,
October 1, 2000;
11(10):
1798 - 1806.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. E. Sorensen and I. Novak
Visualization of ATP Release in Pancreatic Acini in Response to Cholinergic Stimulus. USE OF FLUORESCENT PROBES AND CONFOCAL MICROSCOPY
J. Biol. Chem.,
August 24, 2001;
276(35):
32925 - 32932.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|